The CA 19-9 test in combination with the CEA test is a useful adjunct for monitoring carcinoma of the stomach; however, the sensitivity of performing these assays concurrently is comparable to performing the CEA assay alone in gastric carcinoma (11). The gene discussed is CEACAM5; the disease is gastric carcinoma.